Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-019279
Filing Date
2021-01-27
Accepted
2021-01-27 16:58:16
Documents
5
Effectiveness Date
2021-01-27

Document Format Files

Seq Description Document Type Size
1 S-8 d916648ds8.htm S-8 76055
2 EX-5.1 d916648dex51.htm EX-5.1 12137
3 EX-23.1 d916648dex231.htm EX-23.1 1676
4 GRAPHIC g916648dtp01.jpg GRAPHIC 2187
5 GRAPHIC g916648g0122005153570.jpg GRAPHIC 1785
  Complete submission text file 0001193125-21-019279.txt   96672
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-252480 | Film No.: 21560626
SIC: 2834 Pharmaceutical Preparations